Skip to main content
Clinical Trials/EUCTR2015-002019-13-HU
EUCTR2015-002019-13-HU
Active, not recruiting
Not Applicable

Reversal of deep pipecuronium neuromuscular block usingsugammadex: a randomized, double-blind, dosefindingstudy

niversity of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy0 sitesAugust 19, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
The effect of sugammadex dose on deep neuromuscular blockade willbe investigated, therefore patients suffering from various conditionsundergoing surgery in general anaesthesia with muscle relaxation willbe included in the study.
Sponsor
niversity of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy
Status
Active, not recruiting
Last Updated
10 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 19, 2015
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient aged 18\-65 undergoing general surgery under combined
  • general anaesthesia with neuromuscular
  • 2\. ASA (American Society of Anesthesiology) physical status score 1\-3
  • 3\. BMI (Body\-Mass Index) 18,5\-25
  • 4\. duration of operation over 100 minutes
  • 5\. need for intratracheal intubation
  • 6\. supine position, at least one arm accessible
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes

Exclusion Criteria

  • 1\. diseases influencing neuromuscular function (myopathies, significant
  • renal or hepatic insufficiency)
  • 2\. drugs influencing neuromuscular function (magnesium,
  • aminoglycosides)
  • 3\. gravidity, lactation
  • 4\. urgent surgery
  • 5\. chronic obstructive pulmonary disease
  • 6\. glaucoma
  • 7\. difficult airway management possible

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Reversal of pipecuronium neuromuscular block using sugammadexThe effect of sugammadex dose on residual neuromuscular blockade willbe investigated, therefore patients suffering from various conditionsundergoing surgery in general anaesthesia with muscle relaxation willbe included in the study.Therapeutic area: Body processes [G] - Physiological processes [G07]
EUCTR2012-000259-14-HUniversity of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy
Not yet recruiting
Not Applicable
Reversal of rocuronium induced neuromuscular block by sugammadex for electroconvulsive therapy; crossover designed dose response studyPsychiatric disease
JPRN-UMIN000007254Tokyo Women's Medical University Hospital20
Active, not recruiting
Not Applicable
Reversal of neuromuscular block using sugammadex
EUCTR2011-001683-22-HUniversity of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy
Completed
Not Applicable
Rocuronium-induced neuromuscular block and reversibility with sugammadex at the corrugator supercilii and adductor pollicis musclesSurgical patients requiring general anesthesia
JPRN-UMIN000010240ihon University of Medicine Department of Anesthesiology40
Active, not recruiting
Phase 1
Recovery from deep neuromuscular blockade using different sugammadex doses in elderly patients undergoing laparoscopic robot-assisted prostatectomy: a prospective, randomized, double-blind clinical trial (RECIR)Deep neuromuscular block in patients undergoing RALP under general anaesthesiaMedDRA version: 21.1Level: PTClassification code 10057286Term: Neuromuscular blockade reversalSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2020-004704-34-ITFONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE34